Private Trust Company’s Immunogen Inc IMGN Stock Holding History

Private Trust Company’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-360	Closed	-$4K	–	1254
2014 Q3	$4K	Hold	360	–	–	﹤0.01%	1400
2014 Q2	$4K	Hold	360	–	–	﹤0.01%	1405
2014 Q1	$5K	Hold	360	–	–	﹤0.01%	1201
2013 Q4	$5K	Hold	360	–	–	﹤0.01%	1182
2013 Q3	$6K	Hold	360	–	–	﹤0.01%	1100
2013 Q2	$6K	Buy	+360	New	+$5.83K	﹤0.01%	1021

Other funds holding IMGN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Private Trust Company's IMGN Position: Q4 2014 in Review

Private Trust Company sold out of Immunogen Inc (IMGN) in Q4 2014, closing a stake of 360 shares — an estimated $4K sold.

Private Trust Company first reported a position in IMGN in Q2 2013 and held it in 6 quarters. The position peaked at $6K in Q3 2013. 131 funds tracked by Wall St. Rank hold IMGN as of Q4 2014.

Private Trust Company reported no remaining Immunogen Inc position as of Q4 2014 after selling out during the quarter.
Private Trust Company sold 360 Immunogen Inc shares in Q4 2014, an estimated $4K.
Private Trust Company first reported a position in Immunogen Inc in Q2 2013 and held it in 6 quarters.
Private Trust Company's Immunogen Inc position peaked at $6K in Q3 2013.
131 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.